Global Drug Discovery Informatics Market to Reach USD 8.4 Billion by 2033, Supported by Significant Expansion in the Pharmaceutical Industry

January 07, 2025 | Healthcare

According to the latest report by IMARC Group, titled “Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2025-2033," the global drug discovery informatics market reached a value of USD 3.6 Billion in 2024. Drug discovery informatics (DDI) refer to sophisticated bioinformatic algorithmic solutions that evaluate large volumes of biomechanical data regarding gene expression, drug, and disease. They involve a set of software and hardware-based tools, which assist in protecting databases, discovering drugs for their formulation, docking, interpreting, visualizing, and preparing data. Apart from this, drug discovery informatics aid in generating insights related to the development of several drugs post their experimentation in clinical laboratories and customizing systems for different aspects of data. Consequently, they are extensively used in healthcare institutions, pharmaceuticals, biotechnology organizations, and contract research organizations (CROs) for making clinical decisions, managing trials, and performing pharmacovigilance tasks.


Global Drug Discovery Informatics Market Trends:

The drug discovery informatics market is majorly being driven by the increasing prevalence of various chronic disorders and the growing need for effective medication moieties at affordable prices to treat rare diseases. In line with this, the sudden outbreak of coronavirus disease (COVID-19) infection has prompted governments of several nations to invest in the pharmaceutical industry to perform drug discovery for manufacturing novel vaccines. This, in turn, supplemented the widespread adoption of drug discovery informatics for performing virtual screening of molecules, which is acting as another growth-inducing factor. Additionally, the introduction of in-silico modelling tools and physiologically based pharmacokinetic (PBK) simulator that assists in supporting pediatric dose selection for small molecule drugs and forecasting pharmacokinetic outcomes are contributing to the market growth. Moreover, the extensive deployment of drug discovery informatics in the healthcare sector for managing biological information from multiple sources and analyzing new drug entities is propelling the market growth. Other factors, such as strategic collaborations amongst key players and continuous investments in the research and development (R&D) activities for identifying diverse applications of drug discovery informatics and improving its efficacy, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 8.4 Billion by 2033, growing at a CAGR of 9.21% during 2025-2033.


Market Summary:

  • Based on the workflow, the market has been bifurcated into drug discovery and drug development.
  • On the basis of the function, the market has been segregated into sequence analysis platforms, molecular modelling, molecular docking, clinical trial data management, and others.
  • Based on the mode, the market has been bifurcated into outsourced and in-house.
  • On the basis of the end user, the market has been segmented into pharmaceutical companies, biotechnology companies, contract research organization (CROs), and others.
  • On a regional basis, the market has been categorized into North America (United States, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. 
  • The competitive landscape of the industry has also been examined, along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Workflow, Function, Mode, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Drug Discovery Informatics Market to Reach USD 8.4 Billion by 2033, Supported by Significant Expansion in the Pharmaceutical Industry
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials